This week we were pleased to have Ali Tafreshi visiting from @TopconHealthcare at our weekly #EyeTRU group meeting. Ali was in Copenhagen in connection with our FOREVER Symposium on Wednesday 27 September.
#EyeTRU#FOREVER#TOPCONhealthcare#TOPCON#FOREVERSYMPOSIUM
We are excited & proud to share #EyeTRU group leader @KolkoMiriam's new Lancet paper "Glaucoma: now and beyond", which has just become available online. Together with Hari Jayaram, David Friedman & Gus Gazzard, Miriam has prepared this seminar:
https://t.co/btGnBo6FHx
#Glaucoma
On Sunday 3 September, we had the pleasure of hosting our annual research seminar in the beautiful surroundings of Gunderslevholm Gods.
We're already looking forward to many exciting months until next year's seminar.
Read more here:
https://t.co/SRI4rOj3sd
"The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?"
@AnneNagstrup & @KolkoMiriam just published a review on all the molekyler aspects of anti-glaucomatous eye drops and what to be aware of regarding tolerability.
https://t.co/7gDkgegv7b
#EyeTRU
Congratulations to #EyeTRU member Umalbaninn Alnoor (Al Moussawi) who successfully defended her thesis project about the survival and function of conjunctival goblet cells.
Keep up the excellent work and we can’t wait to follow your exciting path.
#thesisproject#dkforsk#dksund
Last month PhD students @ZaynabMouhammad and Mariana García did a research stay at Karolinska Institutet with @pete_the_teapot and James Tribble. Both are working on basic research projects. We can't wait to see the results of their experiments.
#EyeTRU#research#projects#phd
Today #EyeTRU members Simone Ahrensberg, Arevak Saruhanian and @Pernille_MD_H is attending the Fight for Sight, Denmark's annual grant recipient ceremoni. All three have received research funding for respectively research projects and ph.d project.
Congratulations to them all.
Good news for the many patients with Glaucoma. @KolkoMiriam and Øjenforeningen has through dialogue with the Danish Medicines Agency & research made it prohibited to replace the toxic preservative, BAK, in eye drops where the original does not contain BAK.
https://t.co/w5LtsLO8tI
Laboratory technician Jeff Bair visiting #EyeTRU from Massachusetts Eye and Ear infirmary in Boston, USA, as part of our goblet cell collaborations.
#kolkogroup#dksund#dkforsk@UCPH_health
We are very pleased to share that the first paper from #ProjectFOREVER about the entire project design has been published! We encourage you to read about the FOREVER design and the new Danish Eye and Vision Cohort: https://t.co/Z5997wiYpD Josefine Freiberg @JRovelt @KolkoMiriam